In recent years, GLP‑1 medications such as semaglutide and tirzepatide have become widely known for their ability to support weight loss. But for people in addiction recovery, these medications have sparked a different kind of conversation — one that goes beyond weight and into the deeper neurobiology of cravings, impulse control, and reward.